AR057409A1 - Heterociclos oxigenados como moduladores de receptores de progesterona. composiciones farmaceuticas. - Google Patents
Heterociclos oxigenados como moduladores de receptores de progesterona. composiciones farmaceuticas.Info
- Publication number
- AR057409A1 AR057409A1 ARP060102752A ARP060102752A AR057409A1 AR 057409 A1 AR057409 A1 AR 057409A1 AR P060102752 A ARP060102752 A AR P060102752A AR P060102752 A ARP060102752 A AR P060102752A AR 057409 A1 AR057409 A1 AR 057409A1
- Authority
- AR
- Argentina
- Prior art keywords
- nrcrd
- alkyl
- alkenyl
- atom
- alkynyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
- C07D307/88—Benzo [c] furans; Hydrogenated benzo [c] furans with one oxygen atom directly attached in position 1 or 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/94—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom spiro-condensed with carbocyclic rings or ring systems, e.g. griseofulvins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D307/83—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Reproductive Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102005030294A DE102005030294A1 (de) | 2005-06-24 | 2005-06-24 | Nichtsteroidale Progesteronrezeptor-Modulatoren |
Publications (1)
Publication Number | Publication Date |
---|---|
AR057409A1 true AR057409A1 (es) | 2007-12-05 |
Family
ID=36716643
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP060102752A AR057409A1 (es) | 2005-06-24 | 2006-06-27 | Heterociclos oxigenados como moduladores de receptores de progesterona. composiciones farmaceuticas. |
Country Status (22)
Country | Link |
---|---|
EP (1) | EP1899315A1 (de) |
JP (1) | JP2008543911A (de) |
KR (1) | KR20080018275A (de) |
CN (1) | CN101248056A (de) |
AR (1) | AR057409A1 (de) |
AU (1) | AU2006261049A1 (de) |
BR (1) | BRPI0612305A2 (de) |
CA (1) | CA2611900A1 (de) |
CR (1) | CR9595A (de) |
DE (1) | DE102005030294A1 (de) |
DO (1) | DOP2006000150A (de) |
EA (1) | EA200702604A1 (de) |
EC (1) | ECSP078043A (de) |
GT (1) | GT200600272A (de) |
IL (1) | IL188022A0 (de) |
MX (1) | MX2008000070A (de) |
NO (1) | NO20080441L (de) |
PE (1) | PE20070170A1 (de) |
TW (1) | TW200738665A (de) |
UY (1) | UY29626A1 (de) |
WO (1) | WO2006136462A1 (de) |
ZA (1) | ZA200800689B (de) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UY30805A1 (es) * | 2006-12-21 | 2008-07-31 | Bayer Schering Pharma Ag | Moduladores no esteroides de receptores de progesterona |
DE102007032800A1 (de) * | 2007-07-10 | 2009-01-15 | Bayer Schering Pharma Aktiengesellschaft | Nichtsteroidale Progesteronrezeptor-Modulatoren |
DE102007058747A1 (de) | 2007-12-05 | 2009-06-10 | Bayer Schering Pharma Aktiengesellschaft | Nichtsteroidale Progesteronrezeptor-Modulatoren |
TWI477276B (zh) * | 2008-04-28 | 2015-03-21 | Repros Therapeutics Inc | 抗黃體素給藥方案 |
CA2872644A1 (en) | 2012-05-31 | 2013-12-05 | Repros Therapeutics Inc. | Formulations and methods for vaginal delivery of antiprogestins |
JP6343619B2 (ja) | 2012-11-02 | 2018-06-13 | レプロス セラピューティクス インコーポレイティド | プロゲステロン依存性病態を処置する方法およびその組成物 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19723722A1 (de) * | 1997-05-30 | 1998-12-10 | Schering Ag | Nichtsteroidale Gestagene |
EP1175422A2 (de) * | 1999-05-04 | 2002-01-30 | Ligand Pharmaceuticals Incorporated | Tetracyclische progesteronrezeptor-modulator-verbindungen und verfahren |
US6358948B1 (en) * | 1999-05-04 | 2002-03-19 | American Home Products Corporation | Quinazolinone and benzoxazine derivatives as progesterone receptor modulators |
US6960581B2 (en) * | 2002-01-14 | 2005-11-01 | Boehringer Ingelheim Pharmaceuticals, Inc. | Glucocorticoid mimetics, methods of making them, pharmaceutical formulations, and uses thereof |
BR0308394A (pt) * | 2002-03-11 | 2005-01-25 | Schering Ag | 5-{2-hidróxi-3-[1-(3-trifluormetilfenil)-ciclopropil]-pr oprionilamino}-ftaleto e compostos relacionados com atividade moduladora de receptores de progesterona para uso em controle da fertilidade e terapia de reposição hormonal |
DE10346939A1 (de) * | 2003-10-06 | 2005-05-19 | Schering Ag | Heterocyclisch substituierte Pentanole, ein Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer |
-
2005
- 2005-06-24 DE DE102005030294A patent/DE102005030294A1/de not_active Ceased
-
2006
- 2006-06-22 AU AU2006261049A patent/AU2006261049A1/en not_active Abandoned
- 2006-06-22 BR BRPI0612305-8A patent/BRPI0612305A2/pt not_active Application Discontinuation
- 2006-06-22 EA EA200702604A patent/EA200702604A1/ru unknown
- 2006-06-22 KR KR1020087001789A patent/KR20080018275A/ko not_active Application Discontinuation
- 2006-06-22 CA CA002611900A patent/CA2611900A1/en not_active Abandoned
- 2006-06-22 CN CNA2006800306699A patent/CN101248056A/zh active Pending
- 2006-06-22 JP JP2008517445A patent/JP2008543911A/ja active Pending
- 2006-06-22 EP EP06762405A patent/EP1899315A1/de not_active Withdrawn
- 2006-06-22 MX MX2008000070A patent/MX2008000070A/es not_active Application Discontinuation
- 2006-06-22 WO PCT/EP2006/006532 patent/WO2006136462A1/de active Application Filing
- 2006-06-23 TW TW095122741A patent/TW200738665A/zh unknown
- 2006-06-26 DO DO2006000150A patent/DOP2006000150A/es unknown
- 2006-06-26 UY UY29626A patent/UY29626A1/es not_active Application Discontinuation
- 2006-06-26 PE PE2006000732A patent/PE20070170A1/es not_active Application Discontinuation
- 2006-06-26 GT GT200600272A patent/GT200600272A/es unknown
- 2006-06-27 AR ARP060102752A patent/AR057409A1/es unknown
-
2007
- 2007-12-10 IL IL188022A patent/IL188022A0/en unknown
- 2007-12-14 CR CR9595A patent/CR9595A/es not_active Application Discontinuation
- 2007-12-21 EC EC2007008043A patent/ECSP078043A/es unknown
-
2008
- 2008-01-23 ZA ZA200800689A patent/ZA200800689B/xx unknown
- 2008-01-23 NO NO20080441A patent/NO20080441L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EA200702604A1 (ru) | 2008-06-30 |
KR20080018275A (ko) | 2008-02-27 |
CN101248056A (zh) | 2008-08-20 |
CA2611900A1 (en) | 2006-12-28 |
GT200600272A (es) | 2007-08-20 |
WO2006136462A1 (de) | 2006-12-28 |
MX2008000070A (es) | 2008-03-19 |
CR9595A (es) | 2008-05-05 |
ECSP078043A (es) | 2008-01-23 |
UY29626A1 (es) | 2007-01-31 |
TW200738665A (en) | 2007-10-16 |
EP1899315A1 (de) | 2008-03-19 |
NO20080441L (no) | 2008-03-07 |
DOP2006000150A (es) | 2006-12-31 |
IL188022A0 (en) | 2008-03-20 |
JP2008543911A (ja) | 2008-12-04 |
BRPI0612305A2 (pt) | 2010-11-03 |
DE102005030294A1 (de) | 2007-01-04 |
AU2006261049A1 (en) | 2006-12-28 |
PE20070170A1 (es) | 2007-03-02 |
ZA200800689B (en) | 2009-07-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR057409A1 (es) | Heterociclos oxigenados como moduladores de receptores de progesterona. composiciones farmaceuticas. | |
PE20211795A1 (es) | Compuestos heteroaril tetraciclicos | |
AR030306A1 (es) | Derivados de piperazina, un procedimiento para su preparacion, composiciones farmaceuticas, un metodo para su fabricacion y el uso de dichos derivados para la fabricacion de un medicamento | |
AR035305A1 (es) | Derivados y analogos del acido 3-arilpropionico, proceso para su preparacion, formulaciones farmaceuticas, uso de los mismos en la elaboracion de medicamentos, y formulacion farmaceutica para usar en la profilaxis y/o tratamiento de trastornos clinicos asociados con la resistencia a la insulina | |
CO6210771A2 (es) | Moduladores 2-aminopirimidina del receptor de histamina h4 | |
AR078756A1 (es) | Moduladores alostericos positivos (map) | |
HRP20110498T1 (hr) | Azetidini kao inhibitori mek za liječenje proliferativnih bolesti | |
AR035518A1 (es) | Derivados de carboxamida, un procedimiento para su preparacion, un medicamento que los contiene, el u so de los mismos para preparar un medicamento, y un conjunto (kit) que los incluye | |
PA8621901A1 (es) | Derivados de sulfonamida para el tratamiento de enfermedades | |
PA8604201A1 (es) | Derivados de 2-amino-piridina utiles para el tratamiento de enfermedades | |
AR081859A1 (es) | Pirimidinas 2,4,6-trisustituidas, composiciones farmaceuticas que las comprenden y su uso en el tratamiento de tumores sensibles a la inhibicion de la cinasa atr | |
AR062695A1 (es) | N-(1- ftalazin -1--il- piperidin -4-il) - amidas como moduladores del receptor ep2 | |
AR082667A1 (es) | 6-cicloalquil-pirazolopirimidinonas para el tratamiento de trastornos del snc | |
PA8517101A1 (es) | Derivados de tropano ùtiles en terapia | |
DOP2005000006A (es) | "derivados de sulfonamida para el tratamiento de enfermedades" | |
ECSP088293A (es) | Inhibidores de gamma secretasa, de sulfonamido n-cíclico puenteado | |
AR054863A1 (es) | DERIVADOS DE 1H-PIRROLO[3, 4-C]PIRAZOL, UN PROCESO PARA SU PREPARACION, COMPOSICIONES FARMACEUTICAS QUE LOS COMPRENDEN Y SU USO EN LA FABRICACION DE UN MEDICAMENTO PARA EL TRATAMIENTO O PROFILAXIS DE ENFERMEDADES ASOCIADAS CON EL FACTOR DE COAGULACIoN XA | |
AR074352A1 (es) | Acidos naftalen-2-il-aceticos sustituidos, composiciones farmaceuticas que los contienen, y uso de los mismos en el tratamiento de enfermedades alergicas,tales como rinitis, asma y dermatitis atopica. | |
AR067075A1 (es) | Derivados de isoxasol - imidazol | |
UY29802A1 (es) | Análogos de la feniletilamina y su uso en el tratamiento del glaucoma | |
ECSP19020742A (es) | DERIVADOS DE CROMANO, ISOCROMANO Y DIHIDROISOBENZOFURANOS COMO MODULADORES ALOSTÉRICOS NEGATIVOS DE mGluR2, COMPOSICIONES Y SU USO | |
AR066604A1 (es) | Derivados de arilamida pirimidona, medicamentos que los contienen y usos terapeuticos para prevenir y/o tratar enfermedades neurodegenerativas fundamentalmente. | |
AR054519A1 (es) | Moduladores no esteroides de receptor de progesterona | |
AR101566A2 (es) | Composición farmacéutica de compuestos heterobicíclicos que contienen nitrógeno | |
AR013152A1 (es) | Derivados de 2-alquilheterodihidropirimidina, proceso para su preparacion, composiciones farmaceuticas que contienen dichos derivados y el uso de dichosderivados y composiciones como ligandos para canales de calcio neuronales de tipo n. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |